Hologic to Present at the 29th Annual Canaccord Adams Global Growth Conference

BEDFORD, Mass., July 13 /PRNewswire-FirstCall/ -- Hologic, Inc. (Nasdaq: HOLX)
today announced that Glenn Muir, Chief Financial Officer, will present at the
29th Annual Canaccord Adams Global Growth Conference in Boston, MA on
Thursday, August 13, 2009 at 8:30 a.m. (Eastern).

Interested parties are invited to listen to live audio webcasts of Hologic's
investor presentations on the investor section of the company's website at
www.hologic.com/investor. Archives of the presentations will be available for
replay following the conferences.

About Hologic, Inc.
Hologic, Inc. is a leading developer, manufacturer and supplier of premium
diagnostics products, medical imaging systems and surgical products dedicated
to serving the healthcare needs of women. Hologic's core business units are
focused on breast health, diagnostics, GYN surgical, and skeletal health.
Hologic provides a comprehensive suite of technologies with products for
mammography and breast biopsy, radiation treatment for early-stage breast
cancer, cervical cancer screening, treatment for menorrhagia, permanent
contraception, osteoporosis assessment, preterm birth risk assessment, mini
C-arm for extremity imaging and molecular diagnostic products including HPV
and reagents for a variety of DNA and RNA analysis applications. For more
information, visit www.hologic.com.

Contact: Deborah Gordon
Vice President, Investor Relations
Hologic, Inc.
(781) 999-7716

SOURCE Hologic, Inc.

Deborah Gordon, Vice President, Investor Relations of Hologic, Inc.,
+1-781-999-7716